On February 1, 2023, the FTC announced a proposed $1.5 million settlement with GoodRx Holdings, based on alleged violations of the Federal Trade Commission Act (“FTC Act”) and Health Breach Notification Rule (“HBNR”) for using advertising technologies on its websites and mobile app that resulted in the unauthorized disclosure of consumers’ personal and health information to advertisers and other third parties. On the same day, the U.S. Department of Justice, acting on behalf of the FTC, filed a Complaint and Proposed Stipulated Order detailing the FTC’s allegations and the terms of the proposed settlement.
Blog Editors
Recent Updates
- NYDFS Cybersecurity Crackdown: New Requirements Now in Force—Are You Compliant?
- Video: New Tips and Overtime Guidance, NLRB Circuit Split, and Stalled Nomination - Employment Law This Week
- Companies and Employees Increasingly at Risk of AI-Powered Cyber Attacks
- Video: New Leadership and Priorities for the EEOC - Employment Law This Week
- Expanded Pay Transparency Requirements Coming to Columbus, Ohio